B Braun Q8000 - 0.9% Sodium Chloride Injection USP, 1000 mL, EXCEL Plus IV Container, 12/CS

B Braun Q8000 - 0.9% Sodium Chloride Injection USP, 1000 mL, EXCEL Plus IV Container, 12/CS

0.9% Sodium Chloride Injection USP, 1000 mL, EXCEL Plus IV Container

• These intravenous solutions are indicated for use in adults and pediatric patients as sources of electrolytes and water for hydration
• Sterile, nonpyrogenic, and contain no bacteriostatic or antimicrobial agents
• Packaging is not manufactured with PVC or DEHP

Each 100 mL of 0.9% Sodium Chloride Injection USP contains:

• Sodium Chloride USP 0.9 g; Water for Injection USP qs
• pH: 5.6 (4.5-7.0) Calculated Osmolarity: 308 mOsmol/liter
• pH adjusted with Hydrochloric Acid NF
• Concentration of Electrolytes (mEq/liter): Sodium 154 Chloride 154

Not made with DEHP, PVC, or natural rubber latex to support you, your patients, and environmental safety.

How are B. Braun IV containers different from those that contain PVC?

B. Braun IV containers are biologically inert and are not made with natural rubber latex, PVC or the plasticizer DEHP. When certain medications come in contact with PVC, there is potential for sorption of the drug and therefore the release of DEHP into the fluid and/or absorption of the active ingredient with subsequent sub-therapeutic dosing. Using B. Braun IV containers minimizes patient exposure to the toxic DEHP plasticizer compared to using PVC containers containing DEHP.

How long and at what temperature can EXCEL Plus IV containers be placed in a warming cabinet?

B. Braun conducted container integrity, as well as chemical and biological stability testing, on the following products to support warming up to 40 dgree clesius for a period of up to 28 days until expiration, whichever is sooner. Products should not be returned to stock after warming.

What are the volume specifications for solutions in the EXCEL Plus IV container?

The fill volumes for EXCEL Plus IV containers account for water vapor transmission loss over the shelf life of the products and volume remaining in the container after drainage. The United States Pharmacopeia (USP) requires containers of injections to have "a volume in slight excess of the labeled 'size' or the volume that is to be withdrawn," referred to as excess volume. For labeled volumes of 50 mL or more, USP <1151> recommends excess volume of 2% (3% for viscous solutions), which is considered sufficient to permit withdrawal and administration of the labeled volume.